• Industry experts note visibility as the biggest Pharma logistics Supply Chain Challenge
• Healthcare tapping into the potential of an increasingly connected world
• ‘IoT’ the cure for industrial connectivity in pharma
• Greater visibility allows for efficiency improvement, costs reduction and an undeniable competitive advantage.
Stephen HartnettVisibility noted as the biggest challenge to pharma logistics
Finally, and despite the conference room table being strewn with Styrofoam coffee cups and half-eaten takeaway, each supply chain planner and quality control inspector breathes a collective sigh of relief as the following message blinks throughout the command centre:
For most, a holiday to Amsterdam is just that: a chance to unwind, enjoy the wonderful Dutch culture, and take in those sights and sounds only found in the Netherlands.
For some, though, a trip to the city may be more than a tulip-filled excursion abroad on account of its more liberal policies when it comes to offering alternative and ground-breaking cancer treatments to those who have tried more traditional means in the battle of their lives.
Think back to those times when either you or yours received troubling, life-altering news.
Perhaps you were at the bank being told you did not qualify for a small-business loan on account of your credit history or, conversely, on the way to the grocers when you received a phone call alerting you to the passing of a loved one.
Nine times out of 10, though, most bad news is delivered in GP offices the world over after you or a close friend receive an unexpected, though not entirely incurable, prognosis. That said, doctors and care teams are quick to begin prescribing medications in line with protocols meant to save one’s life and which patients are wont to take immediately.
The healthcare industry continuously fights to solve the common supply chain management challenges it faces, including the lack of real-time package tracking solutions, optimising time-critical shipments, and securing environmentally-sensitive medicine. Unfortunately, the outcome of this problem often comes down to costly services for the end recipients. Patients, the most vulnerable category, become the bumpers for unforeseen circumstances in the supply chain.
It is an impossible task to put a price tag on human life. When health and wellbeing are concerned, no soon is soon enough. And since more and more people are in need of an urgent ailment fix due to rising prescription drug rates, the costs for delivering indispensable remedies to patients can skyrocket.